Parkinson’s Disease: From Pathophysiology to Novel Therapeutic Approaches—Second Edition

Dear Colleague,

Parkinson’s disease occurs as a result of decreased dopaminergic cells in the substantia nigra. The mechanism behind this decrease in dopaminergic cells remains unknown. About 1% of the population over 60 years of age suffer from Parkinson's disease, and the number of patients with Parkinson’s disease is rapidly increasing with the increase in life expectancy. Treatment strategies for Parkinson’s disease have increased in various ways over the past few years. In addition to drugs, surgery, rehabilitation, and other conventional therapies, many options are becoming a reality, including cell therapy and neurotrophic agents. This Special Issue of Biomedicines aims to investigate the novel mechanisms involved in Parkinson’s disease and further develop novel therapeutic strategies. Original articles and reviews are welcome for publication on the topic.

Dr. Sujung Yeo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• parkinson’s disease
• alpha-synuclein
• dopaminergic neuron
• pathology
• therapy
• neurodegeneration
• neuroprotection